• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Anxa6/miR-9-5p/Anxa2 轴调控 TGF-β1 诱导的小鼠肝星状细胞(mHSC)活化和 CCl 致肝纤维化。

The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl-caused liver fibrosis.

机构信息

Department of Hepatopathy, The Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410005, China.

Department of Hepatopathy, The Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha 410005, China.

出版信息

Toxicol Lett. 2022 Jun 1;362:38-49. doi: 10.1016/j.toxlet.2022.04.004. Epub 2022 Apr 26.

DOI:10.1016/j.toxlet.2022.04.004
PMID:35483553
Abstract

Chronic liver disease such as hepatic fibrosis is a major cause of morbidity and mortality and has been related to high individual risk of hepatocellular carcinoma (HCC). Hepatic stellate cells (HSCs) activation is a central event of hepatic fibrosis progression. In this study, the up-regulation of lncRNA ANXA2P2 (mouse Anxa6) was found in liver fibrosis. Within CCl-caused liver fibrosis murine model, Anxa6 knockdown partially ameliorated CCl-induced hepatic fibrosis and blocked the PI3K/Akt signaling activation. In TGF-β1-stimulated HSCs, Anxa6 knockdown partially inhibited TGF-β1-induced HSC activation and blocked the PI3K/Akt signaling activation. Mouse Anxa6 downstream mmu-miR-9-5p directly targeted Anxa2; Anxa6 negatively regulated mmu-miR-9-5p, and mmu-miR-9-5p negatively regulated mouse Anxa2. In TGF-β1-stimulated HSCs, miR-9-5p inhibitor promoted TGF-β1-induced HSC activation and PI3K/Akt signaling activation, whereas Anxa2 knockdown exerted opposite effects; Anxa2 knockdown significantly attenuated miR-9-5p inhibitor effects upon TGF-β1-stimulated HSCs. In conclusion, lncRNA ANXA2P2 (mouse Anxa6) expression is up-regulated in hepatic fibrosis and exerts pro-fibrotic effects on CCl-caused liver fibrosis model mice and TGF-β1-stimulated HSCs. The mouse Anxa6/miR-9-5p/Anxa2 axis and the PI3K/Akt pathway might participate in the functions of lncRNA ANXA2P2 (mouse Anxa6) on hepatic fibrosis.

摘要

慢性肝脏疾病,如肝纤维化,是发病率和死亡率的主要原因,并且与肝细胞癌(HCC)的个体高风险相关。肝星状细胞(HSCs)的激活是肝纤维化进展的核心事件。在本研究中,发现在肝纤维化中长链非编码 RNA ANXA2P2(小鼠 Anxa6)上调。在 CCl 引起的肝纤维化小鼠模型中,Anxa6 敲低部分改善了 CCl 引起的肝纤维化,并阻断了 PI3K/Akt 信号激活。在 TGF-β1 刺激的 HSCs 中,Anxa6 敲低部分抑制了 TGF-β1 诱导的 HSC 激活,并阻断了 PI3K/Akt 信号激活。小鼠 Anxa6 的下游 mmu-miR-9-5p 直接靶向 Anxa2;Anxa6 负调控 mmu-miR-9-5p,而 mmu-miR-9-5p 负调控小鼠 Anxa2。在 TGF-β1 刺激的 HSCs 中,miR-9-5p 抑制剂促进了 TGF-β1 诱导的 HSC 激活和 PI3K/Akt 信号激活,而 Anxa2 敲低则产生相反的效果;Anxa2 敲低显著减弱了 miR-9-5p 抑制剂对 TGF-β1 刺激的 HSCs 的作用。总之,长链非编码 RNA ANXA2P2(小鼠 Anxa6)在肝纤维化中表达上调,并对 CCl 引起的肝纤维化模型小鼠和 TGF-β1 刺激的 HSCs 发挥促纤维化作用。小鼠 Anxa6/miR-9-5p/Anxa2 轴和 PI3K/Akt 途径可能参与了长链非编码 RNA ANXA2P2(小鼠 Anxa6)在肝纤维化中的功能。

相似文献

1
The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl-caused liver fibrosis.Anxa6/miR-9-5p/Anxa2 轴调控 TGF-β1 诱导的小鼠肝星状细胞(mHSC)活化和 CCl 致肝纤维化。
Toxicol Lett. 2022 Jun 1;362:38-49. doi: 10.1016/j.toxlet.2022.04.004. Epub 2022 Apr 26.
2
Igf2bp2 knockdown improves CCl-induced liver fibrosis and TGF-β-activated mouse hepatic stellate cells by regulating Tgfbr1.Igf2bp2 敲低通过调节 Tgfbr1 改善 CCl 诱导的肝纤维化和 TGF-β激活的小鼠肝星状细胞。
Int Immunopharmacol. 2022 Sep;110:108987. doi: 10.1016/j.intimp.2022.108987. Epub 2022 Jul 9.
3
Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.miR-188-5p 的抑制通过 PTEN/PI3K/AKT 通路显著减少 HSCs 的活化和增殖,从而减轻肝纤维化。
J Cell Mol Med. 2021 Apr;25(8):4073-4087. doi: 10.1111/jcmm.16376. Epub 2021 Mar 10.
4
A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation.一个长链非编码 RNA Gpr137b-ps/miR-200a-3p/CXCL14 轴调节肝星状细胞 (HSC) 激活。
Toxicol Lett. 2021 Jan 1;336:21-31. doi: 10.1016/j.toxlet.2020.10.001. Epub 2020 Oct 15.
5
The miR-139-5p/peripheral myelin protein 22 axis modulates TGF-β-induced hepatic stellate cell activation and CCl-induced hepatic fibrosis in mice.miR-139-5p/外周髓鞘蛋白 22 轴调控 TGF-β诱导的肝星状细胞活化和 CCl 诱导的肝纤维化在小鼠中。
Life Sci. 2021 Jul 1;276:119294. doi: 10.1016/j.lfs.2021.119294. Epub 2021 Mar 3.
6
Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.表观遗传调控的微小RNA-9-5p通过转化生长因子β受体1和转化生长因子β受体2抑制肝星状细胞的激活。
Cell Physiol Biochem. 2017;43(6):2242-2252. doi: 10.1159/000484303. Epub 2017 Oct 27.
7
The miR-3074/BMP7 axis regulates TGF-β-caused activation of hepatic stellate cells in vitro and CCl-caused murine liver fibrosis in vivo.miR-3074/BMP7 轴调节 TGF-β 引起的肝星状细胞体外激活和 CCl 引起的小鼠肝纤维化。
Hum Cell. 2024 Mar;37(2):435-450. doi: 10.1007/s13577-023-01017-y. Epub 2024 Jan 14.
8
MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.微小 RNA-34a-5p 通过调控肝星状细胞中 TGF-β1/Smad3 通路抑制肝纤维化。
Cell Biol Int. 2018 Sep;42(10):1370-1376. doi: 10.1002/cbin.11022. Epub 2018 Aug 10.
9
Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.黄芪汤作为一种复方中药,通过调节长链非编码RNA-C18orf26-1/微小RNA-663a/转化生长因子-β轴来抑制肝星状细胞的增殖和激活。
J Integr Med. 2023 Jan;21(1):47-61. doi: 10.1016/j.joim.2022.11.002. Epub 2022 Nov 16.
10
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression.miR-488-5p 通过抑制 TET3 表达减轻肝星状细胞活化和肝纤维化。
Hepatol Int. 2023 Apr;17(2):463-475. doi: 10.1007/s12072-022-10404-w. Epub 2022 Aug 24.

引用本文的文献

1
Role of the Annexin A protein family in liver diseases: insights and therapeutic opportunities.膜联蛋白A蛋白家族在肝脏疾病中的作用:见解与治疗机遇
Front Pharmacol. 2025 Jul 11;16:1569927. doi: 10.3389/fphar.2025.1569927. eCollection 2025.
2
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development.整合到增强子的乙肝病毒序列作为致癌驱动因子,通过表观遗传促进肝细胞癌发展。
J Exp Clin Cancer Res. 2025 May 22;44(1):155. doi: 10.1186/s13046-025-03413-8.
3
Qinggan Yipi capsule ameliorates hepatic fibrosis in rats by down-regulating the TGF-β1/Smad2/3 signaling pathway and improving gut microbiota imbalance.
清肝抑脾胶囊通过下调TGF-β1/Smad2/3信号通路和改善肠道微生物群失衡来改善大鼠肝纤维化。
Front Pharmacol. 2025 Jan 24;16:1525914. doi: 10.3389/fphar.2025.1525914. eCollection 2025.
4
The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis.微小RNA及其他非编码RNA在乙型肝炎病毒(HBV)相关肝纤维化形成中的交互作用
Funct Integr Genomics. 2025 Jan 23;25(1):24. doi: 10.1007/s10142-024-01519-4.
5
Signaling pathways that activate hepatic stellate cells during liver fibrosis.在肝纤维化过程中激活肝星状细胞的信号通路。
Front Med (Lausanne). 2024 Sep 18;11:1454980. doi: 10.3389/fmed.2024.1454980. eCollection 2024.
6
Noncoding RNA-Mediated Epigenetic Regulation in Hepatic Stellate Cells of Liver Fibrosis.非编码RNA介导的肝纤维化肝星状细胞中的表观遗传调控
Noncoding RNA. 2024 Aug 7;10(4):44. doi: 10.3390/ncrna10040044.
7
LncRNA /IGFBP3 axis is involved in liver fibrosis by promoting the proliferation and activation of mouse hepatic stellate cells.长链非编码RNA/胰岛素样生长因子结合蛋白3轴通过促进小鼠肝星状细胞的增殖和激活参与肝纤维化过程。
J Cell Commun Signal. 2024 May 28;18(2):e12033. doi: 10.1002/ccs3.12033. eCollection 2024 Jun.
8
Phillygenin Inhibits TGF-β1-induced Hepatic Stellate Cell Activation and Inflammation: Regulation of the Bax/Bcl-2 and Wnt/β-catenin Pathways.知母皂苷元抑制转化生长因子-β1诱导的肝星状细胞活化和炎症:对Bax/Bcl-2和Wnt/β-连环蛋白信号通路的调控
Inflammation. 2024 Aug;47(4):1403-1422. doi: 10.1007/s10753-024-01984-w. Epub 2024 Feb 23.
9
Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD.机器学习确定与铁死亡相关的基因 ANXA2 为 NAFLD 的潜在诊断生物标志物。
Front Endocrinol (Lausanne). 2023 Dec 19;14:1303426. doi: 10.3389/fendo.2023.1303426. eCollection 2023.
10
Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy.肝纤维化相关微小RNA的相互作用:分子机制及其在诊断和治疗中的意义
Genes Dis. 2022 Sep 5;10(4):1457-1469. doi: 10.1016/j.gendis.2022.08.013. eCollection 2023 Jul.